Clinical Artificial Intelligence Applications in Radiology: Neuro

Summary
The most recent advances of AI in neuroradiology are presented.
- These include applications related to differential diagnosis, image acquisition, prediction of genetic mutations, lesion quantification, identification of critical findings, prognostication, and others.
- A brief review of machine learning competitions in neuroradiology is given.
- The first case of reimbursement for an AI algorithm is described.
Neuroradiology examples
The number of AI applications in neuroradiology is increasing every day, which include differential diagnosis of diseases, improvements in image acquisition (both quality and time), prediction of genetic mutations from MR imaging, segmentation of anatomy to guide interventional procedures, segmentation to quantify CNS lesions, identification of critical findings to shorten notification time, prognostication of diseases, quality assurance of patient position during image acquisition, and many
Machine Learning Competitions
ML challenges are complementary to hypothesis-driven research. Various ML competitions in the health care domain have occurred on many platforms, with Kaggle.com and Grand-challenge.org being the most well-known platforms. The Medical Image Computing and Computer Assisted Intervention Society has organized most ML competitions in neuroimaging. The Radiological Society of North America has launched competitions with the largest, publicly available, expertly annotated datasets comprising images
Centers for Medicare and Medicaid Services approval
At the end of 2020, the CMS granted Viz.ai the first New Technology Add-on Payment (NTAP) for its LVO detection algorithm. Medicare will pay up to $1040 per use in patients with stroke. The decision was based on prospective evidence that the tool improves clinical and financial outcomes, such as shortening the time to treatment and length of stay.66 However, the modified Rankin Scale (mRS) at discharge had no statistically significant improvement in this study.66 Another study (preprint) showed
Reviews
Interested readers are invited to read other published reviews, which keep growing in number every month.2,68, 69, 70, 71, 72, 73, 74, 75 One of the first, “Machine Learning Studies on Major Brain Diseases: 5-Year Trends of 2014-2018,” summarizes the evidence and current limitations of 209 articles published between 2014 and 2018 and emphasizes the limited sample size in most papers.68 Another good review to start with is “Deep Learning in Neuroradiology,” which outlines methods used to develop
Clinics care points
- There are countless use-cases of AI in neuroradiology, most of which show no proper external validation.
- Both external validation and prospective clinical trials demonstrating improved outcomes are lacking for neuroradiology AI software.
- Some models have regulatory approval, but this is not a guarantee of model performance in real-world clinical settings or better health care outcomes.
- CMS approved the first case of reimbursement for AI software, an LVO identification software that was shown to
Summary
In this article, many promising use-cases of AI in neuroradiology are presented. However, there is a large gap between proof of concept and robust, prospectively validated algorithms. Most AI applications in neuroradiology fall in the former group. Although external validation is increasingly required for medical AI journal publication, this is just the first step toward safe and meaningful use of AI, which requires prospective trials. Regulatory approval does not guarantee model performance in
Disclosure
F.C. Kitamura and I. Pan are consultants for MD.ai. F.C. Kitamura is a speaker for GE Healthcare. The other authors have nothing to disclose.


